Managing Anemia Associated With Olaparib for Relapsed Ovarian Cancer
What are the recommendations for managing anemia in patients receiving olaparib?
All articles by Jiajoyce R. Conway, DNP, CRNP, AOCNP
Best Practices for Handling BCG Waste
What is the proper procedure for handling bacillus Calmette-Guerin (BCG) waste? Does the room need to be closed off after instilling the drug into the bladder?
Guidelines for Flushing IV Lines Between Medications
Are there any published studies regarding the amount of saline used to flush a line before the next medication can be hung?
Drug Classification of Trastuzumab
Is trastuzumab classified as an immunotherapy? If so, how does it work?
Evolution of HER2-Positive Breast Cancer: Yesterday, Today, and Tomorrow
A review of HER2-positive breast cancer, including etiology, diagnosis, and treatments.
Mitomycin Extravasation Protocol
What is the protocol for extravasation of Mitomycin C?
Monitoring Patients With Chronic Lymphocytic Leukemia Treated With Venetoclax
What are key monitoring guidelines for patients with CLL being treated with venetoclax?
Common Oncologic Emergencies That Occur With Multiple Myeloma
What are the common oncologic emergencies seen in patients with MM?
Handling Closed System Device-Incompatible Chemotherapy Agents
How can accidental exposure/leaks when handling chemotherapy drugs that incompatible with the closed system device (CSD) be prevented?
Port functionality with irinotecan administration
Subcutaneous power ports seem to rarely function properly when administering irinotecan but function properly when the regimen changes. Is there an explanation for why this happens?
Next post in Advisor Forum
